Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Reuters
Reuters
Business

Daiichi Sankyo says it has begun producing AstraZeneca's COVID-19 vaccine in Japan

FILE PHOTO: A syringe with a dose of the vaccine against the coronavirus disease (COVID-19) is displayed at the Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital in Tokyo, Japan March 5, 2021. Yoshikazu Tsuno/Pool via REUTERS

Daiichi Sankyo Co said on Friday it had begun the production of AstraZeneca Plc's COVID-19 vaccine in Japan.

The drugmaker said in a release it will prepare the vaccine in Japan, including vial filling and packaging, using the bulk solution provided by AstraZeneca.

The Japanese government has already arranged to buy 120 million doses of AstraZeneca's vaccine, enough for 60 million people. Most of the doses will be made in Japan by Daiichi Sankyo, JCR Pharma and other local partners.

(Reporting by Rocky Swift; Editing by Jacqueline Wong)

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.